Selective laser trabeculoplasty (SLT) is an advanced non-thermal nanosecond laser treatment that’s clinically proven by the LiGHT trial to be a safe and effective first-line therapy for the treatment of primary open-angle glaucoma or ocular hypertension.1
Ellex’s Tango Reflex Neo, incorporating proprietary SLT technology, delivers advanced energy control, a homogenous sharp-edged aiming beam, and the industry’s fastest firing rate of up to 4Hz – four shots per second.* It’s a capability that’s being used every day by physicians worldwide to visualise the trabecular meshwork in greater detail, and to perform procedures faster and with improved accuracy, delivering better patient outcomes, reliably, accurately, and safely.
Contact: [email protected]
References
LiGHT study, The Lancet. 393.10175.
*Based on system performance testing. Data on file. Ellex Medical.
